Canaan Partners
http://www.canaan.com/homeCanaan Partners is a venture capital firm that invests in early stage technology and healthcare companies. Since its founding in 1987, Canaan has invested in more than 250 companies including DoubleClick and Match.com.
View Older Stories View More Recent Stories
-
Direct Travel Names Rocketrip as New Partner
-
Agile Stacks Completes Initial Funding Round Led by Canaan Partners
-
Agile Stacks Debuts Early Release of DevOps Automation Service that Enables Enterprises to Deploy Customized Cloud Container Stacks in Minutes
-
Protagonist Therapeutics Appoints Sarah Noonberg, M.D., Ph.D. to the Board of Directors
-
CircleUp And Nielsen Collaboration Fuels Growth Of Early-Stage Consumer Products
-
MindTickle Raises $27 Million in Series B Funding to Accelerate Product Innovation and Global Expansion
-
MindTickle Raises $27 Million in Series B Funding to Accelerate Product Innovation and Global Expansion
-
Rocketrip Names Dan Figenshu Chief Financial Officer
-
Adelman Travel Signs Agreement with Rocketrip
-
Leanplum Transforms Mobile Engagement for the Modern Marketer
-
Rocketrip Announces Duty of Care Integration
-
Rocketrip Wins 2017 Innovative Travel and Expense Technology of the Year Award from PayStream Advisors
-
Emissary Scales Intelligence Network With Entrance Into IT Market, Adding 3,000 Executive Advisors From Fortune 1000 Companies And Key Clients
-
Apartment List Acquires Talent Powerhouse, Maguire & Fish
-
HUM Nutrition Announces Series A Investment With Funding From CircleUp, Imaginary Ventures And Strand Equity
-
Leanplum Raises $47 Million to Build Next Generation Marketing Cloud
-
Positive Pre-Clinical Data Supporting SPX-101 to be Presented at the North American Cystic Fibrosis Conference
-
CircleUp Announces CircleUp Growth Partners, a New $125 Million Fund
-
A.I. Company Founded by Google’s Youngest Employee Partners with Former FBI Hostage Negotiator to Revolutionize Dealmaking
-
Clinical Data from Phase 1 PK/PD Study of Octreotide for Intranasal Delivery to be Presented at North American Neuroendocrine Tumor Society Symposium
-
Spyryx Biosciences Announces First Patient Enrolled in Phase 2 Clinical Trial of SPX-101 for the Treatment of Cystic Fibrosis
-
Form 13F-HR Canaan Partners VII LLC For: Sep 30
-
Mynd Secures Additional 5 Million in Funding Led by Lightspeed Ventures
-
Zugata Partners With Skillshare and The Muse to Help Companies Deliver Personalized Professional Development
-
TechCrunch Disrupt San Francisco 2017 Announces Startup Battlefield Competitors
-
ExecThread Raises $6.5 Million to Accelerate Growth of its Crowdsourced Jobs Platform
-
ExecThread Raises $6.5 Million to Accelerate Growth of its Crowdsourced Jobs Platform
-
Aunt Fannie's Closes $2.5 Million Investment Round Led by RCV Partners, CircleUp and Monica Nassif
-
Truveris Secures $25 Million in New Funding to Help Reduce Cost and Improve Access to Prescription Medications
-
Inova Names Mickey Y. Kim, MD, MBA, Senior Vice President of Research and Commercialization
-
Turo Raises $92M Series D, Acquires Daimler's Croove to Continue Global Expansion
-
Mynd Announces Acquisition Of Pacific Shore Management
-
Ollie Raises $12.6M In Series A Funding To Continue To Disrupt Pet Food Space
-
Leanplum's Analysis Reveals Push Notifications Increase In-App Spend 16% and Drive 9.6X More Users to Buy
-
One of Google’s Youngest Hires Raises $16.3 Million From Investors Including Mark Cuban To Revolutionize Information Discovery
-
PerimeterX Raises $23M to Expand AI-Driven Behavioral Threat Protection Platform That Prevents Bot Attacks
-
Form 13F-HR Canaan Partners VII LLC For: Jun 30
-
Aircall Launches Latest Integration with Kustomer CRM for Support Teams
-
Unchained Labs racks up another one, acquires Trinean!
-
Vivace Therapeutics Comes out of Stealth with $40 Million to Turn Novel Biology into First-in-Class Cancer Therapeutics
-
Diabetes Data Platform Leader Glooko Raises $35 Million in Series C
-
Launching the Biden Cancer Initiative
-
FinTech Innovation Lab Celebrates Seventh Anniversary, Entrepreneurs Debut Breakthrough Technologies in Cybersecurity, Artificial Intelligence and Fraud Detection
-
Spyryx Biosciences Expands Development Award with Cystic Fibrosis Foundation; Presents Phase 1 Data for SPX-101 at the European Cystic Fibrosis Conference
-
Spyryx Biosciences to Present at the 2017 BIO International Convention
-
Eiger Announces Appointment of Biopharmaceutical Industry Veteran David Apelian, MD, PhD, MBA to its Board of Directors
-
Hyalex Orthopaedics Raises $16 Million Series A Financing and Appoints Chief Executive Officer
-
Genome Medical Launches Expert Network for Clinical Genetics
-
Spyryx Biosciences Reports Positive Data on SPX-101 at American Thoracic Society International Conference
-
Iterum Secures $65 Million in Series B Financing

